FCA upholds patent validity, rejects argument that a soundly predicted invention must be obvious

January 10, 2022

Pharma in Brief: The 2021 Year in Review

January 9, 2022

PMPRB Update: further-delayed implementation of Patented Medicines Regulations amendments and new Guidelines

December 23, 2021

PMPRB will not proceed with proposed July 15, 2021 changes to its new Guidelines

December 20, 2021

Federal Court of Appeal provides guidance on disclosure exemptions in ATI requests

October 28, 2021

Canada seeks leave to appeal to the Supreme Court in PMPRB excessive-pricing case

October 7, 2021

Health Canada reports on a national strategy for rare disease drugs

August 11, 2021

PMPRB excessive price decision quashed by Federal Court of Appeal

August 3, 2021

PMPRB Guidelines update: consultation on changes re delayed implementation

July 25, 2021

PMPRB Update: delayed implementation of Patented Medicines Regulations amendments and new Guidelines

July 7, 2021